Alí Duarte, MD
@AliDuarteMD
Followers
3K
Following
4K
Media
183
Statuses
2K
Rheumatologist @mayoclinic | #Lupus & #APS | Clinical lead, LUMEN💡- Lupus Midwest Network | Tweets my own | 🇲🇽in🇺🇸
Mayo Clinic
Joined February 2018
RT @AshimaMakol: ✨A Beautiful evening celebrating 🎉 our graduating #Rheum fellows- Dr. Own & Dr. Yang! 🧑🎓👩🎓. We’re so proud of all you’ve….
0
3
0
RT @PepaSolerR: 🎥🎥🎥 “𝟏𝐫𝐬𝐭 𝐌𝐚𝐲𝐨 𝐂𝐥𝐢𝐧𝐢𝐜 - 𝐕𝐚𝐥𝐥 𝐝’𝐇𝐞𝐛𝐫𝐨𝐧 𝐍𝐄𝐏𝐇𝐑𝐎𝐋𝐎𝐆𝐘 𝐔𝐏𝐃𝐀𝐓𝐄” save the dates 5-6 Sep Barcelona 2025. Register to mundicongres@mu….
0
33
0
RT @Reumaclinic: Great atmosphere, dynamic lectures, and brilliant young researchers from around the world — the perfect recipe for an unfo….
0
7
0
RT @Reumaclinic: First day of EULAR ACR APLAR exchange program. An intense but very productive day.First block of full lectures & .Multipl….
0
6
0
RT @gunnar_heine: Lupus weeks @MarkusAtHome:. Tonight 7:30 CEST (and later on demand) @BradRovin Dr. Ana Malvar.REGENCY. Next Friday 7:30 C….
0
7
0
9/ 🤝 Core principle: Shared decision-making. Clinical nuance, patient preference, and access guide real-world treatment. Guidelines = roadmap, not rules.
1
1
9
8/ 🧒👵 Pediatrics & Older Adults: Tailor doses for age, growth, renal function, and comorbidities. Pediatric-to-adult transition should be intentional.
1
0
5
7/ 🚨 Nonresponse:. From dual → escalate to triple. Already on triple → switch agents or add anti-CD20 (rituximab, obinutuzumab).Always assess adherence and dose first. #RefractoryLN.
2
0
4
6/ ⏳ Treatment Duration: For complete responders, continue immunosuppressives (beyond HCQ) for 3–5 years. Therapy is continuous, not induction/maintenance. #LupusCare.
1
0
4
5/ 💊 Class V LN (Pure Membranous):. If proteinuria ≥1g/g: Use triple therapy (GC + MPAA + CNI). If <1g/g: GC + MPAA, AZA, or CNI > no therapy.Less data here—treatment is tailored.
1
1
5
4/ 💊 Class III/IV ± V LN: Conditionally recommend triple therapy:. Pulse IV steroids → oral taper (≤0.5 mg/kg/day, max 40 mg). One of:.a) MPAA + belimumab.b) MPAA + CNI.
1
1
6
3/ 🔬 Biopsy: Prompt kidney biopsy is key when LN is suspected. Repeat for flare or nonresponse. It confirms diagnosis, LN class, and treatment path.
1
0
3
2/ 🔍 Screening: Strongly recommend screening for proteinuria every 6–12 months in all SLE patients—or sooner during extra-renal flares. Early detection = better outcomes.
2
0
3
1/ 🧵The 2024 ACR Guidelines for Lupus Nephritis (LN) are here! Big shifts in screening, combo therapy, and steroid minimization. Let's break it down. Full text:
1
54
124
Do you have #LUPUS and #BrainFog? Help us develop the Lupus Brain Fog Severity Scale—a validated questionnaire to measure brain fog severity in lupus. Your input is essential. Please participate today & RT to share. More info ⬇️⬇️.
✅ Do you have #LUPUS and #BRAINFOG? If so, we would like to INVITE YOU to contribute to our research STUDY for the development of the Lupus Brain Fog Severity Scale - a questionnaire to assess the characteristics and severity of brainfog in lupus 🦋.LINK:
1
11
30
Gracias a @PanlarLeague por la invitación! Fue un gran honor!.
Thank you @Lupusreference and @AliDuarteMD for your amazing talks on lupus nephritis! It is always a pleasure to listen! #PANLAR2025 @PanlarLeague
1
0
15
RT @Lupusreference: ✅ Thanks to ALL OF YOU who have attended our #lupus sessions today with @AliDuarteMD at #PANLAR2025 🙏 This is the first….
0
7
0
RT @gunnar_heine: We are happy + honoured to host @AliDuarteMD and @HerrmannMd from @mayoclinic for our 15th & 16th @MarkusAtHome @NDTsocia….
0
6
0
RT @Lupusreference: ✅ One of the MAJOR MEETINGS coming soon is #PANLAR2025. I have 3 #lupus talks covering #T2T, refractory #SLE, and the….
0
7
0
RT @TheLancetRheum: NEW Personal View—Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphos….
0
21
0